Mehmet Samur

28PUBLICATIONS
189CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Microelectromechanical systems (MEMS)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 20, 2026
Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.

|Dec 11, 2025
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma.

Anil Aktas Samur, Jill Corre, Srikanth Talluri

|Dec 09, 2025
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.

Denis J Ohlstrom, William C Pilcher, Marina E Michaud

|Nov 18, 2025
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases.

Maroulio Pertesi, Delphine Demangel, Abhishek Niroula

|Oct 17, 2025
ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Mariateresa Fulciniti, Yao Yao, Tommaso Perini

|Jun 09, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur

Pageof 5

Frequent Collaborators

17 joint publications

Nikhil Munshi

13 joint publications

Kenneth C Anderson

7 joint publications

Yu-Tzu Tai

6 joint publications

Jill Corre